Literature DB >> 8746287

The effects of octreotide in a patient with Nelson's syndrome.

F Kelestimur1, C Utas, O Ozbakir, A Selçuklu, O Kandemir, N Ozcan.   

Abstract

We have administered octreotide, 100 micrograms tid, to a 27-year-old man with Nelson's syndrome. After seven days of therapy, adrenocorticotropin levels fell to 54% of initial values, and some shrinkage of the tumour was observed. This study indicates that octreotide therapy may have a role in the treatment of Nelson's syndrome.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8746287      PMCID： PMC2398324          DOI： 10.1136/pgmj.72.843.53

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  6 in total

1.  Inhibition by somatostatin of ACTH secretion in Nelson's syndrome.

Authors:  J B Tyrrell; M Lorenzi; J E Gerich; P H Forsham
Journal:  J Clin Endocrinol Metab       Date:  1975-06       Impact factor: 5.958

2.  Studies on the conditions determining the inhibitory effect of somatostatin on adrenocorticotropin, prolactin and thyrotropin release by cultured rat pituitary cells.

Authors:  S W Lamberts; J Zuyderwijk; F den Holder; P van Koetsveld; L Hofland
Journal:  Neuroendocrinology       Date:  1989-07       Impact factor: 4.914

3.  The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease.

Authors:  S W Lamberts; P Uitterlinden; J M Klijn
Journal:  Acta Endocrinol (Copenh)       Date:  1989-06

4.  Effects of various neuropeptides on the secretion of proopiomelanocortin-derived peptides by a cultured pituitary adenoma causing Nelson's syndrome.

Authors:  T Shibasaki; H Masui
Journal:  J Clin Endocrinol Metab       Date:  1982-11       Impact factor: 5.958

5.  Control of plasma glucose with somatostatin analogue (SMS 201-995) during surgical removal of insulinomas.

Authors:  C Utas; F Kelestimur; A Boyaci; A Saglam
Journal:  Postgrad Med J       Date:  1993-12       Impact factor: 2.401

6.  A met-enkephalin analog inhibits adrenocorticotropin secretion by cultured pituitary cells from a patient with Nelson's syndrome.

Authors:  S W Lamberts; R Oosterom; T Verleun; E G Bons; P Uitterlinden
Journal:  J Clin Endocrinol Metab       Date:  1981-11       Impact factor: 5.958
  6 in total
  6 in total

1.  Adrenocorticotropin responsiveness to acute octreotide administration is not affected by mifepristone premedication in patients with Cushing's disease.

Authors:  Francesco Ferrau; Francesco Trimarchi; Salvatore Cannavo
Journal:  Endocrine       Date:  2014-01-10       Impact factor: 3.633

Review 2.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

Review 3.  The role of somatostatin analogs in Cushing's disease.

Authors:  Joost van der Hoek; Steven W J Lamberts; Leo J Hofland
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

4.  Treatment of Cushing disease: overview and recent findings.

Authors:  Tatiana Mancini; Teresa Porcelli; Andrea Giustina
Journal:  Ther Clin Risk Manag       Date:  2010-10-21       Impact factor: 2.423

Review 5.  Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome.

Authors:  C de Bruin; R A Feelders; S W J Lamberts; L J Hofland
Journal:  Rev Endocr Metab Disord       Date:  2008-07-19       Impact factor: 6.514

6.  Corticotroph tumor progression after bilateral adrenalectomy (Nelson's syndrome): systematic review and expert consensus recommendations.

Authors:  Martin Reincke; Adriana Albani; Guillaume Assie; Irina Bancos; Thierry Brue; Michael Buchfelder; Olivier Chabre; Filippo Ceccato; Andrea Daniele; Mario Detomas; Guido Di Dalmazi; Atanaska Elenkova; James Findling; Ashley B Grossman; Celso E Gomez-Sanchez; Anthony P Heaney; Juergen Honegger; Niki Karavitaki; Andre Lacroix; Edward R Laws; Marco Losa; Masanori Murakami; John Newell-Price; Francesca Pecori Giraldi; Luis G Pérez-Rivas; Rosario Pivonello; William E Rainey; Silviu Sbiera; Jochen Schopohl; Constantine A Stratakis; Marily Theodoropoulou; Elisabeth F C van Rossum; Elena Valassi; Sabina Zacharieva; German Rubinstein; Katrin Ritzel
Journal:  Eur J Endocrinol       Date:  2021-03       Impact factor: 6.664
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.